Showing 1 - 12 of 12 trials

Study Title	Prinicipal Investigator	Stanford Study Status
68Ga-RM2 PET/MRI in Biochemically Recurrent Prostate Cancer	Andrei Iagaru	Recruiting
68Ga-PSMA-11 PET/MRI in Finding Tumors in Patients With Intermediate or High-Risk Prostate Cancer Undergoing Surgery	Andrei Iagaru	Recruiting
68Ga-PSMA PET/CT in Detecting Prostate Cancer Recurrence in Patients With Elevated PSA After Initial Treatment	Andrei Iagaru	Recruiting
Standard PET/CT vs. Digital PET/CT	Andrei Iagaru	Recruiting
18F-FSPG PET/MRI or PET/CT Imaging of Cardiac Sarcoidosis or Inflammation	Andrei Iagaru	Recruiting
A Pilot Study of 68-Ga PSMA 11 PET/MRI and 68-Ga RM2 PET/MRI for Evaluation of Prostate Cancer Response to HIFU or HDR Therapy	Andrei Iagaru	Recruiting
68Ga-RM2 PET/CT in Detecting Regional Nodal and Distant Metastases in Patients With Intermediate or High-Risk Prostate Cancer	Andrei Iagaru	Recruiting
F18 DCFPyL PET/CT in Imaging Participants With Recurrent Prostate Cancer	Andrei Iagaru	Recruiting
A Pilot Study of 68Ga PSMA 11 PET/MRI and 68Ga RM2 PET/MRI for Biopsy Guidance in Patients With Suspected Prostate Cancer	Andrei Iagaru	Recruiting
68-Ga-RM2 PET/MRI in Imaging Patients With Estrogen Receptor-Positive Breast Cancer	Andrei Iagaru	Recruiting
177Lu-PSMA-R2 in Patients With PSMA Positive Progressive, Metastatic, Castration Resistant Prostate Cancer	Andrei Iagaru	Recruiting
Integrin Alpha-v-Beta and [18F]-R01-MG-F2 PET/CT in Measuring Response in Patients With Pancreatic Cancer and Healthy Volunteers	Sanjiv Sam Gambhir, MD, PhD	Recruiting